ISCO Files DEF 14A: Executive Compensation Details
Ticker: ISCO · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 1355790
| Field | Detail |
|---|---|
| Company | International Stem Cell Corp (ISCO) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: ISCO
TL;DR
ISCO DEF 14A out: exec comp details for 2023-2024, equity awards galore.
AI Summary
International Stem Cell Corp (ISCO) filed a DEF 14A on April 24, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted and vested for both "Peo" (presumably principal executive officers) and "NonPeo" (non-principal executive officers) members, covering the periods of 2023 and 2024. Specific dollar amounts and details of these awards are presented within the summary compensation tables.
Why It Matters
This filing provides transparency into how International Stem Cell Corp compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specifics of executive compensation can sometimes signal underlying company performance or governance concerns.
Key Numbers
- 2024 — Fiscal Year (Executive compensation data pertains to this year.)
- 2023 — Fiscal Year (Executive compensation data pertains to this year.)
Key Players & Entities
- International Stem Cell CORP (company) — Filer of the DEF 14A
- 0000950170-25-058111 (filing_id) — Accession number for the filing
- 20250424 (date) — Filing date
- 20250617 (date) — Period of report
- 1231 (date) — Fiscal year end
- BTHC III INC. (company) — Former company name
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to disclose information regarding the solicitation of proxies for the company's annual meeting of shareholders, including details on executive compensation.
What fiscal years are covered by the executive compensation data in this filing?
The executive compensation data presented in this filing covers the fiscal years ending December 31, 2024, and December 31, 2023.
What types of equity awards are detailed in the filing?
The filing details equity awards granted and vested, including those for 'Peo' (principal executive officers) and 'NonPeo' (non-principal executive officers), as well as changes in the fair value of outstanding and unvested equity awards granted in prior years.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 24, 2025.
What was the former name of International Stem Cell Corp?
The former name of International Stem Cell Corp was BTHC III INC., with a name change date of March 10, 2006.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding International Stem Cell CORP (ISCO).